Asthma in pregnancy

Clinical Obstetrics and Gynecology

Volumn 53, Issue 2, 2010, Pages 301-310

  Dombrowski, Mitchell P ^a   Schatz, Michael ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Asthma; Exacerbations; Medications; Pregnancy outcomes; Steptherapy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CETIRIZINE; CIMETIDINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; ERYTHROMYCIN; IPRATROPIUM BROMIDE; IRRITANT AGENT; LEUKOTRIENE; LONG ACTING DRUG; LORATADINE; MONTELUKAST; OXYGEN; PREDNISONE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; BREAST FEEDING; BRONCHOSPASM; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG SYNTHESIS; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GASTROSCHISIS; HEART PALPITATION; HOME CARE; HOSPITAL CARE; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; LABOR; LOW BIRTH WEIGHT; LUNG FUNCTION; MATERNAL MORBIDITY; NEBULIZATION; OXYGENATION; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRENATAL CARE; PRIMARY HEALTH CARE; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; SPIROMETRY; TACHYCARDIA; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; VAGINAL DELIVERY; COMPLICATION; FEMALE; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX;

EID: 77951964227     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181de8906     Document Type: Review

References (21)

1. National Asthma Education and Prevention Program Expert Panel Report: Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115:34-46. Available at http://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg.htm (last accessed 12-30-09).
2. Dombrowski MP, Schatz M, ACOG Practice Bulletin: Asthma in pregnancy. Obstet Gynecol. 2008;111:457-464.
3. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Available at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln. pdf (last accessed 12-30-09).
4. Schatz M, Dombrowski MP, Wise R, et al, for The NICHD Maternal-Fetal Medicine Units Network, and NHLBI. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol. 2003;112:283-288.
5. Schatz M, Dombrowski MP. Asthma in pregnancy. N Engl J Med. 2009;360:1862-1869.
6. Bracken MB, Triche EW, Belanger K, et al. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;1024:739-752.
7. Bakhirebva LN, Schatz M, Jones KL, et al. Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann Allergy Asthma Immunol. 2008;101:137-143.
8. Schatz MS, Dombrowski MP, Wise R, et al, for The NICHD Maternal-Fetal Medicine Units Network, and The NHLBI, Bethesda, MD. Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol. 2006;194:120-126.
9. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax. 2006;61:169-176.
10. Mihrshani S, Belousov E, Marks GB, et al. Pregnancy and birth outcomes in families with asthma. J Asthma. 2003;40:181-187.
11. Dombrowski MP, Schatz M, Wise R, et al, for The NICHD Maternal-Fetal Medicine Units Network, and The NHLBI. Asthma during pregnancy. Obstet Gynecol. 2004;103:5-12.
12. Dombrowski MP, Schatz M, Wise R, et al, for The NICHD Maternal-Fetal Medicine Units Network, and The NHLBI. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol. 2004;190:737-744.
13. Triche EW, Saftlas AF, Belanger D, et al. Association of asthma diagnosis, severity, symptoms, and treatement with risk of preeclampsia. Obstet Gynecol. 2004;104:585-593.
14. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288-1293.
15. Enriquez R, Pingsheng W, Griffen MR, et al. Cessation of asthma medication in early pregnancy. Am J Obstet Gynecol. 2006;195:149-153.
16. Chambers K. Asthma education and outcomes for women of child-bearing age. Case Manager. 2003;14:58-61.
17. Murphy VE, Gibson P, Talbot PI, et al. Severe asthma exacerbations during pregnancy. Obstet Gynecol. 2005;106:1046-1054.
18. Nelson HS, Carr W, Nathan R, et al. ACAAI/AAAAI Joint Task Force Report: update on the safety of long-acting B-agonists in combination with inhaled corticosteroids for the treatment of asthma. Ann Allergy Asthma Immunol. 2009;102:11-15.
19. Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Asthma Immunol. 2007;119:618-625.
20. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysisofepidemiological studies. Teratology. 2000;62:385-392.
21. Schatz M, Dombrowski MP, Wise R, et al, The NICHD Maternal-Fetal Medicine Units Network, and The NHLBI. The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol. 2004;113:1040-1045.